Sonya Myhien Tran, MD | |
7205 W Center Rd, Ste 200, Omaha, NE 68124-2380 | |
(402) 397-6600 | |
Not Available |
Full Name | Sonya Myhien Tran |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 19 Years |
Location | 7205 W Center Rd, Omaha, Nebraska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669544615 | NPI | - | NPPES |
1669544615 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 26415 (Nebraska) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mid-city Ob-gyn Pc | 3779527585 | 15 |
News Archive
Scientists are launching the first clinical trial to test whether drug regimens containing maraviroc, a medication currently approved to treat HIV infection, are also safe and tolerable when taken once daily by HIV-uninfected individuals at increased risk for acquiring HIV infection. The eventual goal is to see if the drug regimens can reduce the risk of infection.
Tumor cells associated with pancreatic cancer often behave like communities by working with each other to increase tumor spread and growth to different organs. Groups of these cancer cells are better than single cancer cells in driving tumor spread, according to new research from the Perelman School of Medicine at the University of Pennsylvania published in Cancer Discovery online in advance of the print issue.
The FDA is drafting new guidelines for testing and approving multidrug cocktails for life-threatening diseases, the Wall Street Journal reports. "Many diseases, such as AIDS, tuberculosis and cancer, require multidrug combinations. Such drug cocktails can prevent the development of drug resistance, because the microbe or cancer cell needs to undergo more mutations to escape several drugs than to escape just one. By attacking the disease in different ways, drug combinations also improve the chances of therapeutic benefit," the newspaper reports (Schoofs, 3/18).
An interview with Dr Natarajan Ranganathan, key founder and Managing Director of Kibow Biotech Inc. about the use of probiotics for supporting healthy kidney function.
After nearly four years of work, a group of researchers and clinicians from the University of Colorado (CU) published a paper this week in the Clinical Cancer Research that shares findings from research looking at how the composition of ovarian cancer tumors changes during chemotherapy and contributes to therapeutic response.
› Verified 7 days ago
Entity Name | Mid-city Ob-gyn Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861578817 PECOS PAC ID: 3779527585 Enrollment ID: O20050613001196 |
News Archive
Scientists are launching the first clinical trial to test whether drug regimens containing maraviroc, a medication currently approved to treat HIV infection, are also safe and tolerable when taken once daily by HIV-uninfected individuals at increased risk for acquiring HIV infection. The eventual goal is to see if the drug regimens can reduce the risk of infection.
Tumor cells associated with pancreatic cancer often behave like communities by working with each other to increase tumor spread and growth to different organs. Groups of these cancer cells are better than single cancer cells in driving tumor spread, according to new research from the Perelman School of Medicine at the University of Pennsylvania published in Cancer Discovery online in advance of the print issue.
The FDA is drafting new guidelines for testing and approving multidrug cocktails for life-threatening diseases, the Wall Street Journal reports. "Many diseases, such as AIDS, tuberculosis and cancer, require multidrug combinations. Such drug cocktails can prevent the development of drug resistance, because the microbe or cancer cell needs to undergo more mutations to escape several drugs than to escape just one. By attacking the disease in different ways, drug combinations also improve the chances of therapeutic benefit," the newspaper reports (Schoofs, 3/18).
An interview with Dr Natarajan Ranganathan, key founder and Managing Director of Kibow Biotech Inc. about the use of probiotics for supporting healthy kidney function.
After nearly four years of work, a group of researchers and clinicians from the University of Colorado (CU) published a paper this week in the Clinical Cancer Research that shares findings from research looking at how the composition of ovarian cancer tumors changes during chemotherapy and contributes to therapeutic response.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Sonya Myhien Tran, MD 7205 W Center Rd, Ste 200, Omaha, NE 68124-2380 Ph: (402) 397-6600 | Sonya Myhien Tran, MD 7205 W Center Rd, Ste 200, Omaha, NE 68124-2380 Ph: (402) 397-6600 |
News Archive
Scientists are launching the first clinical trial to test whether drug regimens containing maraviroc, a medication currently approved to treat HIV infection, are also safe and tolerable when taken once daily by HIV-uninfected individuals at increased risk for acquiring HIV infection. The eventual goal is to see if the drug regimens can reduce the risk of infection.
Tumor cells associated with pancreatic cancer often behave like communities by working with each other to increase tumor spread and growth to different organs. Groups of these cancer cells are better than single cancer cells in driving tumor spread, according to new research from the Perelman School of Medicine at the University of Pennsylvania published in Cancer Discovery online in advance of the print issue.
The FDA is drafting new guidelines for testing and approving multidrug cocktails for life-threatening diseases, the Wall Street Journal reports. "Many diseases, such as AIDS, tuberculosis and cancer, require multidrug combinations. Such drug cocktails can prevent the development of drug resistance, because the microbe or cancer cell needs to undergo more mutations to escape several drugs than to escape just one. By attacking the disease in different ways, drug combinations also improve the chances of therapeutic benefit," the newspaper reports (Schoofs, 3/18).
An interview with Dr Natarajan Ranganathan, key founder and Managing Director of Kibow Biotech Inc. about the use of probiotics for supporting healthy kidney function.
After nearly four years of work, a group of researchers and clinicians from the University of Colorado (CU) published a paper this week in the Clinical Cancer Research that shares findings from research looking at how the composition of ovarian cancer tumors changes during chemotherapy and contributes to therapeutic response.
› Verified 7 days ago
Dr. Elizabeth Stephens Constance, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7308 S 142nd St, Omaha, NE 68138 Phone: 402-717-4200 | |
Jennifer Marie Burgart, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7710 Mercy Rd Ste 202, Omaha, NE 68124 Phone: 402-280-4438 | |
Dr. Grace Binter, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 983255 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6160 | |
Dr. Stephanie Lynn Fisher Gustin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7308 S 142nd St, Omaha, NE 68138 Phone: 402-717-4200 Fax: 402-717-4231 | |
Dr. Alex Keith Laudenklos, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 N 30th St, Cu Department Of Obstetrics And Gynecology, Omaha, NE 68131 Phone: 402-717-0947 | |
Mr. Kent Harry Siemers, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7205 W Center Rd, Suite 200, Omaha, NE 68124 Phone: 402-397-6600 Fax: 402-397-8318 | |
Dr. Brent Jonathan Tierney, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Suite 300, Omaha, NE 68114 Phone: 402-354-5250 Fax: 402-354-3437 |